Essayer OR - Gratuit

Principles and applications of Chromatography & HPLC

Chronicle Pharmabiz

|

September 18, 2025

HIGH-performance liquid chromatography (HPLC) is an important instrument used in the pharmaceutical industry for evaluations and quality control of a large variety of samples.

- P Mandal

It is a chromatographic method that is used to separate a mixture of compounds in analytical chemistry, biochemistry and especially in pharmaceutical industries so as to identify, quantify or purify the individual components of the mixture. It is a method of choice for checking purity of new chemical entities, monitoring changes in synthetic procedures or scale up, evaluating new formulations, and carrying out quality control and the assurance of the final drug product. The present article gives a brief overview of modern HPLC method development especially for pharma industry.

Rapid high-performance liquid chromatography method could improve formulation quality control studies. Researchers say the novel high-performance liquid chromatography with diode-array detection method can be utilised in routine quality control analysis of levofloxacin in pharmaceutical formulation and bioequivalence studies.

Chromatography and HPLC

Selectivity and detectability optimization are the primary goals in HPLC separations. The separation principle of HPLC is based on the distribution of the analyte (sample) between a mobile phase; called eluent and a stationary phase; usually the packing material of the column, which is stationery. Depending on the chemical structure of the analyte, the molecules are retarded while passing the stationary phase.

In gas chromatography (GC), the mobile phase is a gas and the analytes need to have sufficient volatility to pass through the column. In addition, the analytes need to be stable at the temperatures exposed to in the injector and/or in the column. Analytes that are not volatile, for example, fatty acids, can be made volatile by derivatization, e.g., the fatty acids can be converted to esters.

PLUS D'HISTOIRES DE Chronicle Pharmabiz

Chronicle Pharmabiz

Chronicle Pharmabiz

Home-grown CAR-T cell therapies gaining ground

INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.

time to read

4 mins

November 27, 2025

Chronicle Pharmabiz

NPPA extends price fixation on orthopaedic implants for 1 year

IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

FICCI envisages it's Smart AAMs to boost healthcare

In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.

time to read

1 min

November 27, 2025

Chronicle Pharmabiz

DoP asked to bring policy for affordable drug pricing

THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

Ramaiah emphasises need for bone health and osteoporosis diagnosis

RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.

time to read

2 mins

November 27, 2025

Chronicle Pharmabiz

Nathealth calls for action in 2026-27 Union Budget

NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

Hotspots & growth opportunities in biomanufacturing

THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.

time to read

3 mins

November 27, 2025

Chronicle Pharmabiz

Omega Hospitals acquires Cytecare Hospitals

Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.

time to read

2 mins

November 27, 2025

Chronicle Pharmabiz

Devices sector hails withdrawal of QCOs

THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.

time to read

1 min

November 27, 2025

Chronicle Pharmabiz

'There is urgent need for tech-focused regulatory approach for med devices'

THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.

time to read

2 mins

November 27, 2025

Listen

Translate

Share

-
+

Change font size